PD-L1 expression on cancer cells plays multiple roles, including inhibiting interferon-induced apoptosis and accelerating proliferation [5, 6] as well as strong inhibition of anti-tumour T cell responses through binding to the receptor PD1 on T cells [7, 8]. The gene discussed is PDCD1; the disease is neoplasm.